» Articles » PMID: 37051007

Zinc Alpha 2 Glycoprotein As an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients

Overview
Journal Cureus
Date 2023 Apr 13
PMID 37051007
Authors
Affiliations
Soon will be listed here.
Abstract

Background and objectives Microalbuminuria is an early sign of diabetic nephropathy (DN). However, pathological abnormalities occur before the onset of microalbuminuria. Renal impairment progresses in about 50% of cases in type 2 diabetes mellitus (T2DM) without significant albuminuria. Diabetes mellitus (DM) is linked with obesity, metabolic syndrome, and lifestyle changes, where adipokines play an important role. Zinc alpha 2 glycoprotein (ZAGP) is an adipokine, and in this study, it was assessed as a potential biomarker for early DN as well as its progression. Materials and methods This study was a cross-sectional case-control study conducted at a tertiary hospital in northern India. T2DM patients aged 18-65 years old were included in the study and were divided into four groups based on their albuminuria level. This study included 160 participants, with 40 participants in each group. Group I included healthy volunteers, while Groups II, III, and IV were normoalbuminuric, microalbuminuric, and macroalbuminuric diabetic patients, respectively. The groups were evaluated for demographic variables, biochemical parameters, urine albumin-creatinine ratio (UACR), and serum ZAGP. Data between the groups were compared statistically. Results This study included 160 participants, with 40 participants in each group. There was a significant difference between the groups based on the serum ZAGP (p<0.001). Serum ZAGP was significantly negatively correlated with serum creatinine, glycosylated hemoglobin (HbA1c), serum cholesterol, serum triglyceride, low-density lipoprotein (LDL) cholesterol, and UACR. ZAGP was positively correlated with the estimated glomerular filtration rate (eGFR). Conclusion The present study showed that ZAGP was an early biomarker of diabetic nephropathy, and its value decreased as DN progressed. It also suggested that ZAGP, an adipokine, has an anti-inflammatory mechanism of action and its depletion worsens the disease.

Citing Articles

The Associations between Asprosine, Clusterin, Zinc Alpha-2-Glycoprotein, Nuclear Factor Kappa B, and Peroxisome Proliferator-Activated Receptor Gamma in the Development of Complications in Type 2 Diabetes Mellitus.

Senyigit A, Durmus S, Tabak O, Oruc A, Uzun H, Ekinci I J Clin Med. 2024; 13(20).

PMID: 39458076 PMC: 11508428. DOI: 10.3390/jcm13206126.


Association Between Dietary Zinc Intake and Increased Renal Function in US Adults.

Liu C, Zhang H, Yang Y, Cao Y, Liang D Biol Trace Elem Res. 2023; 202(9):3871-3885.

PMID: 38015328 DOI: 10.1007/s12011-023-03969-6.

References
1.
Zhu H, Wang X, Pan H, Gong F, Zhang D, Li N . Serum Levels of the Adipokine Zinc- α 2-glycoprotein Are Decreased in Patients with Hypertension. ISRN Endocrinol. 2014; 2014:374090. PMC: 3934454. DOI: 10.1155/2014/374090. View

2.
Epstein M, Sowers J . Diabetes mellitus and hypertension. Hypertension. 1992; 19(5):403-18. DOI: 10.1161/01.hyp.19.5.403. View

3.
Yeung D, Lam K, Wang Y, Tso A, Xu A . Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. J Clin Endocrinol Metab. 2009; 94(7):2531-6. DOI: 10.1210/jc.2009-0058. View

4.
Xu L, Yu W, Niu M, Zheng C, Qu B, Li Y . Serum ZAG Levels Were Associated with eGFR Mild Decrease in T2DM Patients with Diabetic Nephropathy. Int J Endocrinol. 2017; 2017:5372625. PMC: 5352973. DOI: 10.1155/2017/5372625. View

5.
Ouchi N, Parker J, Lugus J, Walsh K . Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11(2):85-97. PMC: 3518031. DOI: 10.1038/nri2921. View